High Specificity and Purity
The Directed Evolution of the Oxidase ensures the production of the single, most active Oxide isomer , solving the stereoselectivity problem of low efficiency chemical routes.
Zeaxanthin Oxide (e.g., Zeaxanthin Epoxide) is a carotenoid derivative with enhanced antioxidant and photoprotective properties, making it valuable in the pharmaceutical and cosmetic industries. Current production methods often involve chemical synthesis from natural Zeaxanthin , which suffers from Low efficiency in chemical synthesis due to multi-step reactions, low yield, and lack of stereoselectivity. Additionally, the Zeaxanthin Oxide product itself has poor stability due to sensitivity to light, heat, and oxygen, leading to rapid degradation during processing and storage.
CD Biosynsis offers a synthetic biology service focused on the clean and efficient production of specific Zeaxanthin Oxides using Escherichia coli (E. coli). Our core strategy addresses both efficiency and stability issues. The efficiency bottleneck ( low efficiency in chemical synthesis ) is overcome by Modification of zeaxanthin synthesis pathway in Escherichia coli . We engineer E. coli to maximize the metabolic flux towards the Zeaxanthin precursor, followed by the co-expression of the Zeaxanthin pathway genes (CrtE, B, I, Y, Z). We introduce a highly specific, rate-limiting Oxidase (e.g., cytochrome P}450$ or monooxygenase) responsible for the conversion of Zeaxanthin to its Oxide. The key innovation is the Directed evolution of oxidase . We apply directed evolution techniques (saturation mutagenesis, DNA shuffling) to this Oxidase to significantly boost its catalytic efficiency and stereoselectivity for the desired oxide isomer. The stability challenge ( poor stability ) is addressed by generating specific, more robust oxide isomers and potentially co-expressing antioxidant E. coli systems. This integrated biosynthetic route replaces inefficient chemical steps with a single, highly efficient enzymatic conversion, yielding a superior and purer product.
Get a QuoteDeveloping a high-quality Zeaxanthin Oxide product faces these key challenges:
A successful solution must ensure robust Zeaxanthin production and introduce a highly active, specific Oxidase for conversion.
CD Biosynsis utilizes advanced metabolic and enzyme engineering to optimize Zeaxanthin Oxide production in E. coli:
Modification of Zeaxanthin Synthesis Pathway in E. coli
We upregulate the central carbon flux to the MEP pathway and express the complete Crt gene cluster (CrtE, B, I, Y, Z) to maximize Zeaxanthin precursor titer.
Directed Evolution of Oxidase
We use mutagenesis and high-throughput screening to enhance the Oxidase's catalytic efficiency and stereoselectivity for the Zeaxanthin Oxide conversion, addressing low efficiency .
Protein Stabilization Engineering
We introduce stability-enhancing point mutations into the Oxidase and engineer the host environment to reduce reactive oxygen species (ROS), mitigating Oxide degradation ( poor stability ).
Subcellular Localization Optimization
We target the Oxidase to specific cellular membranes (e.g., inner membrane) to maximize its activity near the membrane-localized Zeaxanthin.
This integrated approach ensures high Zeaxanthin supply and a highly specific enzymatic conversion to the desired Oxide isomer with improved stability.
Our Zeaxanthin Oxide engineering service is dedicated to pursuing the following production goals:
High Specificity and Purity
The Directed Evolution of the Oxidase ensures the production of the single, most active Oxide isomer , solving the stereoselectivity problem of low efficiency chemical routes.
Enhanced Product Stability
Host engineering and specific isomer selection yield a more robust product, mitigating the issue of poor stability during processing.
Simplified Production Process Icon
Replacing complex chemical steps with a highly efficient microbial fermentation simplifies manufacturing and reduces reliance on harsh solvents.
High Titer and Yield Icon
Optimized MEP and Crt pathways ensure high precursor flow, maximizing the final Oxide yield per fermentation batch.
Reduced Environmental Impact Icon
Biosynthesis is a greener manufacturing route, avoiding the toxic byproducts and high energy consumption of chemical synthesis.
We provide a sustainable, high-performance, and high-purity biosynthetic route for Zeaxanthin Oxide.
Our Zeaxanthin Oxide strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product specificity.
Explore the potential for a stable, high-efficiency Zeaxanthin Oxide supply. CD Biosynsis provides customized strain and enzyme engineering solutions:
Why is Directed Evolution needed for the Oxidase?
Natural oxidases may not be optimally efficient or selective for the Zeaxanthin Oxide reaction. Directed evolution allows us to rapidly evolve the enzyme to achieve maximal catalytic turnover and stereoselectivity for the desired Oxide isomer, directly overcoming the low efficiency in chemical synthesis challenge.
How does biosynthesis improve Oxide Stability?
Biosynthesis allows the production of the Oxide in a controlled cellular environment, potentially generating a more stable isomer than chemical routes. Furthermore, by engineering the host (e.g., increasing antioxidant levels), we can provide in-situ protection against degradation, mitigating poor stability during production.
What is the challenge with the Zeaxanthin Pathway in E. coli?
Zeaxanthin is a complex carotenoid requiring the balanced expression of up to six heterologous genes (Crt cluster) and high supply from the native MEP pathway. Optimizing the flux to prevent intermediate buildup and maximize the final Zeaxanthin titer is the main metabolic engineering hurdle.
What is the estimated project timeline?
A project involving multi-gene pathway construction, enzyme identification, and extensive directed evolution typically requires 24-28 weeks for final strain delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.